State-of-the-art approaches utilize glycosylation mutants or overexpression of the desired protein product (intending to override the cellular glycosylation machinery), although such mutants either show impaired yield or loss of vitality in com-parison to wild type. Also, rarely glycan components termi-nate in mannose residues, which is essential for uptake via mannose receptors in patients with lysosomal storage dis-eases.
This invention provides a new tool to generate GPs with hypo-allergenic properties in a cost-effective way: In con-trast to current methods, the new technique enables effec-tive production of heterologous GPs by vital plants without impair¬¬ments. The technology is based on genetic modifica-tion of the plant glycosylation pathway.
The technology is applicable to Solanaceous and other plants of agronomical interest. Suppression of a specific enzyme results in a general reduction of cross-reactive car-bohydrate determinants (CCD) in all tissues, leading to GPs that are better tolerated and taken up by humans.
Further Information: PDF
Phone: +49 (0)208/94105 10
Dipl.-Ing. Alfred Schillert
firstname.lastname@example.org | TechnologieAllianz e.V.
Microarray to determine responsiveness of tumors to antiangiogenic treatment
06.12.2016 | TechnologieAllianz e.V.
Peltier Adsorption Trap
29.11.2016 | TechnologieAllianz e.V.
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
08.12.2016 | Physics and Astronomy
08.12.2016 | Health and Medicine
08.12.2016 | Life Sciences